To Study the effect of addition of clonidine to methylprednisolone in Selective Spinal Nerve Root Block For curing lower back pain
Phase 3
Not yet recruiting
- Conditions
- Other specified mononeuropathies of lower limb,
- Registration Number
- CTRI/2020/10/028350
- Lead Sponsor
- Indira Gandhi Medical College And Hospital
- Brief Summary
Injections in the spine are used in situations where surgery is not indicated for PIVD.These injections help in reduction of the pain, decrease patient symptoms, have long term pain relief, decrease use of frequent pain medication. Assesment of patients done on the basis of VAS score, Likert Scale, American Chronic Pain Association Quality of Life Scale. The purpose of the study is to see the effects of addition of clonidine to methylprednisolone in selective spinal nerve root block
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients of age groups 30.
- 60 years of either sex, visiting the pain clinic for low back pain with associated radiculopathy of duration more than 2 weeks having already had failed medication and physiotherapy trial.
Exclusion Criteria
- 1.Patient refusal.
- 2.Age less than 18 years.
- 3.Bleeding tendencies.
- 4.Hypersensitivity 5.History of previous surgery in lumbar area.
- 6.Localised infection.
- 7.Patients with history of recent trauma to lumbar area.
- 8.Patients with paraplegia or paraparesis.
- 9.Untreated fractures of spine.
- 10.Patients with heart diseases.
- 11.Lower extremity weakness.
- 12.Allergy to Iodine contrast medium.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS Score 30 days
- Secondary Outcome Measures
Name Time Method Likert Scale American Chronic Pain Association Quality Of Life Scale
Trial Locations
- Locations (1)
Indira Gandhi Medical College And Hospital
🇮🇳Shimla, HIMACHAL PRADESH, India
Indira Gandhi Medical College And Hospital🇮🇳Shimla, HIMACHAL PRADESH, IndiaDr Ravikant DograPrincipal investigator9418465978drravikantdogra@gmail.com